Bank of Montreal
AXDX

Bank of Montreal’s Accelerate Diagnostics AXDX Stock Holding History

Bank of Montreal’s Portfolio AXDX Stock Details AXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-850
Closed -$74K – 5058
2020
Q4 		$74K Hold
850
– – ﹤0.01% 3740
2020
Q3 		$92K Buy
850
+650
+325% +$90.2K ﹤0.01% 3121
2020
Q2 		$33K Buy
+200
New +$19.7K ﹤0.01% 3618
2020
Q1 		– Sell
-240
Closed -$41K – 4101
2019
Q4 		$41K Sell
240
-5,500
-96% -$908K ﹤0.01% 3935
2019
Q3 		$1.07M Buy
5,740
+2,470
+76% +$477K ﹤0.01% 2040
2019
Q2 		$748K Buy
3,270
+2,760
+541% +$540K ﹤0.01% 2217
2019
Q1 		$107K Sell
510
-400
-44% -$75K ﹤0.01% 3025
2018
Q4 		$105K Buy
+910
New +$135K ﹤0.01% 2929
2018
Q3 		– Sell
-2,090
Closed -$466K – 4725
2018
Q2 		$466K Sell
2,090
-5,070
-71% -$1.13M ﹤0.01% 2370
2018
Q1 		$1.64M Buy
7,160
+3,300
+85% +$867K ﹤0.01% 1655
2017
Q4 		$1.01M Buy
+3,860
New +$905K ﹤0.01% 1947
2017
Q1 		– Sell
-450
Closed -$112K – 3963
2016
Q4 		$112K Hold
450
– – ﹤0.01% 2777
2016
Q3 		$123K Buy
450
+350
+350% +$77.4K ﹤0.01% 2671
2016
Q2 		$14K Hold
100
– – ﹤0.01% 3485
2016
Q1 		$14K Buy
+100
New +$14.1K ﹤0.01% 3508

Other funds holding AXDX

GAM
Griffin Asset Management New York $949M AUM 24.98% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
CIA
Cladis Investment Advisory Billings, Montana $182M AUM 33.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BAM
Belpointe Asset Management Reno, Nevada $3.06B AUM 23.82% 1-Year Est. Return

Bank of Montreal's AXDX Position: Q2 2022 in Review

Bank of Montreal sold out of Accelerate Diagnostics (AXDX) in Q2 2022, closing a stake of 1,845 shares — an estimated $27K sold.

Bank of Montreal first reported a position in AXDX in Q2 2014 and held it in 28 quarters. The position peaked at $1.65M in Q1 2018. 74 funds tracked by Wall St. Rank hold AXDX as of Q2 2022.

  • Bank of Montreal reported no remaining Accelerate Diagnostics position as of Q2 2022 after selling out during the quarter.
  • Bank of Montreal sold 1,845 Accelerate Diagnostics shares in Q2 2022, an estimated $27K.
  • Bank of Montreal first reported a position in Accelerate Diagnostics in Q2 2014 and held it in 28 quarters.
  • Bank of Montreal's Accelerate Diagnostics position peaked at $1.65M in Q1 2018.
  • 74 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q2 2022.

Based on Bank of Montreal's 13F filing for Q2 2022, filed 11 Aug 2022.